Abstract
In comparison to other research areas, antibacterial drug discovery provides many opportunities to employ nuclear magnetic resonance (NMR) spectroscopy in the process of drug discovery. First of all, there are a large number of validated targets that can be cloned and expressed and their biological function is well understood. Most targets can be over-expressed readily and purified at quantities needed for NMR. Meanwhile, structural information is frequently available for at least one representative of a given target. Furthermore, enzyme substrates and corresponding inhibitors are often available and characterized. In combination, these factors make NMR studies for bacterial targets both feasible and economical in industrial research.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Betz M, Saxena K, Schwalbe H (2006) Biomolecular NMR: a chaperone to drug discovery. Curr Opin Chem Biol 10:219–225
Cai M, Huang Y, Sakaguchi K et al (1998) An efficient and cost-effective isotope labeling protocol for proteins expressed in Escherichia coli. J Biomol NMR 11:97–102
Cavanagh J, Fairbrother WJ, Palmer AG III et al (2006) Protein NMR spectroscopy: principles and practice. Elsevier Science, Technology, Oxford
Clore GM, Gronenborn AM (1982) Theory and applications of the transferred nuclear overhauser effect to the study of the conformations of small ligands bound to proteins. J Magn Reson 48:402–417
Dalvit C, Pevarello P, Tato M et al (2000) Identification of compounds with binding affinity to proteins via magnetization transfer from bulk water. J Biomol NMR 18:65–68
Dalvit C, Fogliatto G, Stewart A et al (2001) WaterLOGSY as a method for primary NMR screening: practical aspects and range of applicability. J Biomol NMR 21:349–359
Emanuele JJJ, Jin H, Yanchunas J et al (1997) Evaluation of the kinetic mechanism of Escherichia coli uridine diphosphate-N-acetylmuramate: L-alanine ligase. Biochemistry 36:7264–7271
Ernst RR, Bodenhausen G, Wokaun A (1990) Principles of nuclear magnetic resonance in one and two dimensions. Clarendon Press, 2004 ISBN 0198556470, 9780198556473
Fejzo J, Lepre CA, Peng JW et al (1999) The SHAPES strategy: an NMR-based approach for lead generation in drug discovery. Chem Biol 6:755–769
Gharbi-Benarous J, Evrard-Todeschi N, Ladam P et al (1999) Conformational analysis of josamycin, a 16-membered macrolide free in solution and bound to bacterial ribosomes. J Chem Soc Perkin Trans 2:529–544
Gossert AD, Henry C, Blommers MJJ et al (2009) Time efficient detection of protein-ligand interactions with the polarization optimized PO-WaterLOGSY NMR experiment. J Biomol NMR 43:211–217
Hajduk PJ, Olejniczak ET, Fesik SW (1997) One-dimensional relaxation- and diffusion-edited NMR methods for screening compounds that bind to macromolecules. J Am Chem Soc 119:12257–12261
Hajduk PJ, Mack JC, Olejniczak ET et al (2004) SOS-NMR: a saturation transfer NMR-based method for determining the structures of protein-ligand complexes. J Am Chem Soc 126:2390–2398
Huang X, Lee MS (2004) NMR in drug discovery. Front Biotechnol Pharm 4:338–349
Jahnke W (2003) NMR in drug discovery. Chimia 57:59
Johnson EC, Feher VA, Peng JW et al (2003) Application of NMR SHAPES screening to an RNA target. J Am Chem Soc 125:15724–15725
Lahiri S, Mills S (2006) Crystal structure of haemophilus influenzae NAD-dependent DNA ligase A and its uses for molecular modeling of substrate modulators. PCT Int Appl 2005-GB3125; 2004-600667, 90
Lepre CA, Moore JM, Peng JW (2004) Theory and applications of NMR-based screening in pharmaceutical research. Chem Rev 104:3641–3675 (Washington, DC, US)
Levitt MH (2008) Spin dynamics: basics of nuclear magnetic resonance. Wiley, Chichester
Lundqvist T et al (2007) Exploitation of structural and regulatory diversity in glutamate racemases. Nature 447:817–822
Mayer M, Meyer B (1999) Characterization of ligand binding by saturation transfer difference NMR spectroscopy. Angew Chem Int Ed 38:1784–1788
Mayer M, Meyer B (2001) Group epitope mapping by saturation transfer difference NMR to identify segments of a ligand in direct contact with a protein receptor. J Am Chem Soc 123:6108–6117
Palmer AGIII, Kroenke CD, Loria JP (2001) Nuclear magnetic resonance methods for quantifying microsecond-to-millisecond motions in biological macromolecules. Methods Enzymol 339:204–238
Pervushin K, Riek R, Wider G et al (1997) Attenuated T2 relaxation by mutual cancellation of dipole-dipole coupling and chemical shift anisotropy indicates an avenue to NMR structures of very large biological macromolecules in solution. Proc Natl Acad Sci USA 94:12366–12371
Plesniak LA, Botsch K, Leibrand M et al (2008) Transferred NOE and saturation transfer difference NMR studies of novobiocin binding to EnvZ suggest binding mode similar to DNA gyrase. Chem Biol Drug Des 71:28–35
Pochapsky SS, Pochapsky TC (2001) Nuclear magnetic resonance as a tool in drug discovery, metabolism and disposition. Curr Top Med Chem 1:427–441 (Hilversum, Neth)
Powers R (2009) Advances in nuclear magnetic resonance for drug discovery. Expert Opin Drug Discov 4:1077–1098
Sanders CR, Sonnichsen F (2006) Solution NMR of membrane proteins: practice and challenges. Magn Reson Chem 44:S24–S40
Sprangers R, Kay LE (2007) Quantitative dynamics and binding studies of the 20 S proteasome by NMR. Nature 445:618–622 (London, UK)
Stockman BJ, Dalvit C (2002) NMR screening techniques in drug discovery and drug design. Prog Nucl Magn Reson Spectrosc 41:187–231
Tugarinov V, Kay LE (2003) Ile, leu, and val methyl assignments of the 723-residue malate synthase g using a new labeling strategy and novel NMR methods. J Am Chem Soc 125:13868–13878
Tugarinov V, Kay LE (2004) An isotope labeling strategy for methyl TROSY spectroscopy. J Biomol NMR 28:165–172
Wishart D (2005) NMR spectroscopy and protein structure determination: applications to drug discovery and development. Curr Pharm Biotechnol 6:105–120
Zartler ER, Shapiro MJ (2006) Protein NMR-based screening in drug discovery. Curr Pharm Des 12:3963–3972
Zawadzke LE, Norcia M, Desbonnet CR et al (2008) Identification of an inhibitor of the MurC enzyme, which catalyzes an essential step in the peptidoglycan precursor synthesis pathway. Assay Drug Dev Technol 6:95–103
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Hu, J., Kern, G. (2012). NMR in Infection Research. In: Dougherty, T., Pucci, M. (eds) Antibiotic Discovery and Development. Springer, Boston, MA. https://doi.org/10.1007/978-1-4614-1400-1_32
Download citation
DOI: https://doi.org/10.1007/978-1-4614-1400-1_32
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4614-1399-8
Online ISBN: 978-1-4614-1400-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)